Aardvark.
knowledge market
- Reports this week
- 0
- Active events
- 0
- Connections
- 20
What's happening
One to three months ago
Gone quiet
No new reports in 90+ daysNo events began in the chosen period. Widen it, or reset.
Around Aardvark this week
News at the entities that move Aardvark most-
FDA StructuralFDA issued a warning letter to NeoGen regarding a product quality defect on October 7, 2026.Moves Aardvark
-
Phillip Kim TransactionalPhillip Kim was contacted regarding a securities lawsuit involving Nvidia on November 9, 2026.Moves Aardvark
-
company OperationalA company operates in Gadsden, Alabama.Moves Aardvark
-
Royal Bank of Canada Mentioned togetherMorgan Stanley began coverage of Vylor with an 'overweight' rating, while Royal Bank of Canada authorized a $3.00 billion stock buyback plan.Moves Aardvark
Connections
The 8 strongest of 20, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
FDA Structural
FDA has placed a clinical hold on Aardvark's IND application, impacting its development timeline.
-
David Zhang Structural
David Zhang serves as a member of Aardvark's Board of Directors.
-
Bryan Jones Structural
Bryan Jones served as the former Chief Operating Officer of Aardvark Therapeutics.
-
COURT Structural
Aardvark's securities are subject to judicial action and regulation by the Court in securities class actions.
-
company Operational
Aardvark is the subject of a class action lawsuit regarding securities fraud.
-
Phillip Kim Transactional
Phillip Kim is providing legal assistance to Aardvark's investors regarding a lawsuit.
-
Josh Wilson Mentioned together
Josh Wilson has publicly commented on Aardvark's financial performance and losses to investors.
-
Royal Bank of Canada Mentioned together
The single snapshot describes a general activity by Royal Bank of Canada without mentioning Aardvark, indicating no observed coupling.